infectious diseases - Microviable Therapeutics S.L.

Microviable Therapeutics seeks more than five million to secure a clinical trial

adminMicroVi2023-09-07T09:03:29+02:007 de September de 2023|

Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]

Microviable Therapeutics will be presenting at AIMID 2022 Meeting

adminMicroVi2022-09-16T11:00:49+02:0016 de September de 2022|

Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]